We are live on ! Find out more
SCM

Shelton Capital Management Portfolio holdings

AUM $4.57B
1-Year Est. Return 32.26%
This Fund
S&P 500
This Quarter Est. Return
+6.56%
1 Year Est. Return
+32.26%
3 Year Est. Return
+110.31%
5 Year Est. Return
+153.06%
10 Year Est. Return
+630.09%
AUM
$3.68B
AUM Growth
+$162M
Cap. Flow
+$16.3M
Cap. Flow %
0.44%
Top 10 Hldgs %
35.65%
Holding
775
New
35
Increased
133
Reduced
392
Closed
59

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$12.1M
2
MSFT icon
Microsoft
MSFT
+$11.3M
3
TRMB icon
Trimble
TRMB
+$8.95M
4
C icon
Citigroup
C
+$7.74M
5
UNH icon
UnitedHealth
UNH
+$6.61M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$22.4M
2
MCHP icon
Microchip Technology
MCHP
+$12.1M
3
TJX icon
TJX Companies
TJX
+$9.71M
4
WFC icon
Wells Fargo
WFC
+$6.6M
5
IRM icon
Iron Mountain
IRM
+$6.54M

Sector Composition

Rank Sector Weight
1 Technology 42.3%
2 Communication Services 12.12%
3 Consumer Discretionary 11.05%
4 Healthcare 8.43%
5 Industrials 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PM icon
276
Philip Morris
PM
$295B
$975K 0.03%
9,621
-600
-6% -$58.7K
COR icon
277
Cencora
COR
$61.2B
$965K 0.03%
4,282
-20
-0.5% -$4.63K
TAP icon
278
Molson Coors Class B
TAP
$8.09B
$935K 0.03%
18,400
– –
ERII icon
279
Energy Recovery
ERII
$443M
$935K 0.03%
70,350
-65,000
-48% -$896K
VLTO icon
280
Veralto
VLTO
$24B
$935K 0.03%
9,789
-132
-1% -$12.6K
GS icon
281
Goldman Sachs
GS
$303B
$882K 0.02%
1,951
– –
VSTS icon
282
Vestis
VSTS
$1.88B
$871K 0.02%
71,187
– –
MMM icon
283
3M
MMM
$94.3B
$855K 0.02%
8,368
+4,340
+108% +$423K
E icon
284
ENI
E
$77.5B
$851K 0.02%
27,627
-1,112
-4% -$35.3K
NVS icon
285
Novartis
NVS
$297B
$839K 0.02%
7,878
-208
-3% -$20.9K
VUG icon
286
Vanguard Morningstar Growth ETF
VUG
$230B
$823K 0.02%
13,200
– –
FIZZ icon
287
National Beverage
FIZZ
$3.01B
$781K 0.02%
15,251
– –
AAPL icon
288
PUT
Apple
AAPL
$4.57T
$780K 0.02%
15,200
+14,842
+4,146% +$2.77M
MTZ icon
289
MasTec
MTZ
$21.9B
$777K 0.02%
7,262
+1,357
+23% +$137K
CSL icon
290
Carlisle Companies
CSL
$15.4B
$774K 0.02%
1,909
-147
-7% -$59.2K
P
291
Everpure Inc
P
$29.9B
$756K 0.02%
11,771
-641
-5% -$37.1K
ELV icon
292
Elevance Health
ELV
$85.5B
$753K 0.02%
1,390
– –
TM icon
293
Toyota
TM
$225B
$743K 0.02%
3,626
-103
-3% -$22.8K
BLK icon
294
Blackrock
BLK
$176B
$730K 0.02%
927
– –
BX icon
295
Blackstone
BX
$110B
$723K 0.02%
5,844
– –
WSM icon
296
Williams-Sonoma
WSM
$29.6B
$720K 0.02%
5,100
-318
-6% -$47.4K
CB icon
297
Chubb
CB
$135B
$692K 0.02%
2,714
– –
LII icon
298
Lennox International
LII
$15.2B
$685K 0.02%
1,280
-71
-5% -$35K
SYK icon
299
Stryker
SYK
$130B
$681K 0.02%
2,000
– –
EME icon
300
Emcor
EME
$36B
$671K 0.02%
1,837
-192
-9% -$70.8K
10 11
12
13 14

Similar funds

SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $4.53B AUM 21.1% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
JRP
Jasper Ridge Partners Menlo Park, California $4.49B AUM 18.72% 1-Year Est. Return
ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return

Shelton Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Shelton Capital Management held 775 positions worth $3.68B, up 4.6% from $3.52B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Shelton Capital Management's Q2 2024 filing shows 35 new, 133 increased, 392 reduced and 59 closed positions. Its largest new stake was Corcept Therapeutics: 140,494 shares worth $4.56M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $22.4M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 39% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Shelton Capital Management's largest Q2 2024 buy was Corcept Therapeutics: 140,494 shares worth $4.56M.
  • Shelton Capital Management added most to NVIDIA in Q2 2024, an estimated $12.1M increase.
  • Shelton Capital Management's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $22.4M.
  • Shelton Capital Management fully exited Brookfield Renewable in Q2 2024, selling an estimated $4.6M.
  • Shelton Capital Management's ten largest holdings make up 36% of its $3.68B portfolio in Q2 2024.
  • Shelton Capital Management opened 35 new positions and closed 59 in Q2 2024.
  • Shelton Capital Management's portfolio value rose 4.6% quarter-over-quarter to $3.68B.

Based on Shelton Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.